Passer au contenu principal

Votre navigateur n’est malheureusement pas entièrement pris en charge. Si vous avez la possibilité de le faire, veuillez passer à une version plus récente ou utiliser Mozilla Firefox, Microsoft Edge, Google Chrome, ou Safari 14 ou plus récent. Si vous n’y parvenez pas et que vous avez besoin d’aide, veuillez nous faire part de vos commentaires.

Nous vous serions reconnaissants de nous faire part de vos commentaires sur cette nouvelle expérience.Faites-nous part de votre opinion S’ouvre dans une nouvelle fenêtre

Elsevier
Publier avec nous

Committee & Speakers

Conference Chairs

Dorothee Dormann, Johannes Gutenberg University, Mainz, Germany

Fen-Biao Gao, University of Massachusetts Chan Medical School, USA

Aaron Gitler, University of Stanford, USA

Speakers

Keynote Victor Ambros, University of Massachusetts Chan Medical School, USA

Session 1: Dysregulated RNA metabolism in neurological diseases Pietro Fratta, University of College London, UK Leslie Thompson, University of California, Irvine, USA

Session 2: Physiological functions of disease-linked RNA-binding proteins Joel Richter, University of Massachusetts Chan Medical School, USA Gene Yeo, University of California, San Diego, USA

Session 3: Biomolecular condensates and their role in normal RNA processing and in disease Simon Alberti, Dresden University of Technology, Germany Roy Parker, University of Colorado, Boulder, USA

Session 4: Human genetics and genomics insights into neurological diseases Don Cleveland, University of California, San Diego, USA Rosa Rademakers, VIB Center for Molecular Neurology, Antwerp, Belgium

Session 5: Structural insights into pathological RNA-binding proteins Magdalini Polymenidou, University of Zürich, Switzerland Ben Ryskeldi-Falcon, MRC Cambridge, UK

Session 6: Toxicity of repeat RNAs and repeat proteins Dieter Edbauer, German Center for Neurodegenerative Diseases, Munich, Germany Laura Ranum, University of Florida, USA

Session 7: Novel biomarkers due to dysregulated RNA metabolism Michael Ward, National Institutes of Health, USA Philip Wong, The John Hopkins University, USA

Session 8: RNA-based therapeutics Anastasia Khvorova, University of Massachusetts Chan Medical School, USA Matthew Simon, Denali Therapeutics, USA